Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis


Comparing PCV2 gilt vaccination protocols and progeny status

Porcine circovirus type 2 (PCV2) is the principal etiological agent of porcine circovirus associated disease (PCVAD), which can cost producers an estimated $3 to $4 per pig.

“Because vertical transmission is a common pathway to exposing pigs to PCV2, stabilizing the sow herd has become a positive management practice,” Kate Mathes, veterinary student at Iowa State University, told Pig Health Today.

Mathes set up a study1 with the following objectives:

  • Evaluate the association of pregnant gilts’ PCV2 status with their progeny’s PCV2 status.
  • Determine if an additional PCV2 vaccination for the gilts would impact the progeny’s PCV2 status.

Materials and methods

For the study, gilts from two sources were randomly selected from the first two deliveries to a brand-new sow farm. A total of 100 gilts, 25 to 28 weeks of age, were divided equally between the two sources.

All of the gilts received two full doses of a PCV2 vaccine prior to reaching the sow farm, with a third dose administered upon arrival. Blood samples were collected from each gilt upon arrival and again at pregnancy confirmation. The gilts were then randomly allocated to one of two treatment groups:

  • Group 1 (n = 50) was re-vaccinated with a full dose of a PCV2 vaccine (for a total of four vaccinations).
  • Group 2 (n = 50) did not receive an additional vaccine.

After farrowing, piglet processing fluids were collected from each litter, and three piglets — small, medium and large — were selected from each litter and ear-tagged. Blood samples were collected from those pigs at weaning.

Serum samples for gilts were tested individually at pregnancy confirmation, whereas piglet samples were pooled by litter for polymerase chain reaction (PCR) PCV2 testing. Processing fluids also were analyzed by litter with PCR.

“As the study progressed, 40 gilts were removed for various reasons unrelated to treatment — 28 in Group 1 and 32 in Group 2,” Mathes said. “For those animals, neither the gilt nor the associated litter data were used.”

She also noted that cross-fostering was not allowed for the participating litters. A cycle threshold value greater than or equal to 37 was considered negative for PCV2.

The outcome

Upon arriving at the sow farm, 69% of gilts from source A and 88% from source B tested PCR-positive for PCV2. The study showed that vaccination protocol — Group 1 versus Group 2 — had no significant effect on PCV2 status for processing fluids or weaned-pig serum. Also, there was no statistical association between the gilts’ PCV2 status at pregnancy confirmation and the individual litter’s status at processing. (See the accompanying table.)

“The additional PCV2 vaccination administered to pregnant gilts at 42 days of gestation in this study had no impact on the gilts’ or piglets’ PCV2 status,” Mathes said. “Future studies should consider gilt status prior to breeding and the role of environmental contamination in processing-fluid collection.”

 Table 1. Gilt PCV2 serum status at pregnancy check compared to offspring PCV2 processing-fluid status


Litter positive

Litter negative Total

Gilt positive

7 3


Gilt negative

22 28


Total 29 31




1Mathes K, et al. Porcine circovirus type 2 (PCV2) stabilization of replacement gilts by vaccination and the impact on offspring PCV2 status. Student Research Posters. Am Assoc. Swine Vet Annual Meeting. 2020;261.


Share It
Would an additional porcine circovirus type 2 vaccination for gilts impact their progeny’s PCV2 status? See the results of a recent study.

Click an icon to share this information with your industry contacts.

Posted on May 13, 2020

tags: , , ,
  • Virus persistence challenges PRRS management strategies

    Eliminating porcine reproductive and respiratory syndrome virus (PRRSV) from pigs might not yet be possible, but monitoring tools could help refine a herd's PRRSV stability.

  • Research continues to dig for POP answers

    Searching for strategies to alter the course of pelvic organ prolapse (POP) in sows has been a long, slow climb with progress coming little by little. At the heart of the effort is the Sow Survivability project

  • Johnson: Five steps for porcine circovirus control

    Some breed-to-wean farms that have been vaccinated for porcine circovirus (PCV) have experienced breakdowns in their control of the virus. Clayton Johnson, DVM, outlines his top five steps for managing PCV outbreaks.

  • High prevalence of PCV2 recombinants highlights importance of broad vaccine coverage

    DISCOVERIES, Issue 21: A recent analysis of porcine circovirus type 2 (PCV2) genetic sequences shows that up to 25% of field strains are recombinants of diverse genotypes, highlighting the importance of broad protection when selecting a PCV2 vaccine.

You must be logged in to edit your profile.

Share It
US producers and veterinarians have seen an influx of different types of influenza viruses in the last 10 to 15 years, and that is a major reason why influenza is more difficult to control.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.